COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01188707
Recruitment Status : Terminated (Dose over MTD reached)
First Posted : August 25, 2010
Last Update Posted : August 4, 2011
Copenhagen University Hospital at Herlev
Bispebjerg Hospital
Roche Pharma AG
Information provided by:
Herlev Hospital

No Study Results Posted on for this Study
Recruitment Status : Terminated
Estimated Primary Completion Date : March 2012
Estimated Study Completion Date : August 2012